According to GlobalData, the worldwide thrombectomy device market was worth $2.96 billion in 2024 and is set to register a ...

2025年2月19日，史赛克（Stryker）正式宣布完成了对Inari Medical的收购。此前，史赛克已宣布达成了一项价值49亿美元（折合360亿人民币）的交易，旨在收购这家专注于静脉血栓栓塞（VTE）治疗的公司。

The Portage, Michigan–based orthopedic and surgical device giant announced last month that it struck a deal to acquire Inari ...

"Stryker concludes Inari Medical acquisition for $4.9bn" was originally created and published by Medical Device Network, a ...

Inari’s expertise combined with Stryker’s existing distribution and logistics network could boost volume and procedure ...

今日，市值达1,468.7亿美元的医疗技术行业领导者Stryker Corporation宣布完成对Inari Medical, Inc.的收购，这标志着其产品组合的重大扩张。 根据今日最终确定的交易，收购对价约为49.4亿美元现金。据 InvestingPro 分析，Stryker保持着强健的财务状况，且负债水平适中。

花旗更新后的财务模型考虑了Inari对Stryker业绩的预期贡献。预计Inari在2025年约10个月期间将产生5.9亿美元的收入。尽管预计Inari将使Stryker的营业利润率降低0-20基点，但预计也将为每股收益（EPS）增加0.20至0.30美元。

“The acquisition of Inari Medical marks a significant milestone in expanding our interventional endovascular portfolio,” said Kevin Lobo, Chair and Chief Executive Officer, Stryker. “We look forward ...

Stryker has completed the previously announced acquisition of Inari Medical for a total equity value of nearly $4.9bn, marking a significant expansion into the venous thromboembolism (VTE ...

Citi resumed coverage of Stryker (SYK) with a Buy rating and $450 price target following the close of the Inari acquisition tryker has built a ...

19, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the acquisition of Inari Medical, Inc. (NASDAQ: NARI), a company ...